These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23155791)

  • 1. Pharmacological management of acute spinal cord injury.
    Sharma A
    J Assoc Physicians India; 2012 May; 60 Suppl():13-8. PubMed ID: 23155791
    [No Abstract]   [Full Text] [Related]  

  • 2. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Crit Care Nurs Q; 1999 Aug; 22(2):44-50. PubMed ID: 10646442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for improving injury outcome in spinal cord injuries.
    Werner PC
    West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687
    [No Abstract]   [Full Text] [Related]  

  • 4. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Pharm Pract Manag Q; 2000 Apr; 20(1):21-7. PubMed ID: 10947539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of pharmacologic therapies for spinal cord injury.
    Zeidman SM; Ling GS; Ducker TB; Ellenbogen RG
    J Spinal Disord; 1996 Oct; 9(5):367-80. PubMed ID: 8938604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings MG; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    J Neurosurg; 1998 Nov; 89(5):699-706. PubMed ID: 9817404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spinal cord injuries and corticotherapy. The NASCIS II study and feasibility].
    Graftieaux JP; Bertault R; Gomis P; Barré J
    Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():42-7. PubMed ID: 8074341
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylprednisolone in acute spinal cord injury: is there any other ethical choice?
    Rozet I
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):137-9. PubMed ID: 18362777
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological interventions for acute spinal cord injury.
    Bracken MB
    Cochrane Database Syst Rev; 2000; (2):CD001046. PubMed ID: 10796741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone in acute spinal cord injury: fact or fantasy?
    Walker J; Criddle LM
    J Emerg Nurs; 2001 Aug; 27(4):401-3. PubMed ID: 11468638
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone.
    Young W; DeCrescito V; Flamm ES; Blight AR; Gruner JA
    Clin Neurosurg; 1988; 34():675-97. PubMed ID: 3378379
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylprednisolone and other confounders to spinal cord injury clinical trials.
    Sipski ML; Pearse DD
    Nat Clin Pract Neurol; 2006 Aug; 2(8):402-3. PubMed ID: 16932592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned].
    Kronvall E; Sayer FT; Nilsson OG
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1887-8, 1890. PubMed ID: 16044768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological therapy after acute cervical spinal cord injury.
    Chappell ET
    Neurosurgery; 2002 Sep; 51(3):855-6; author reply 856. PubMed ID: 12229872
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylprednisolone for the treatment of acute spinal cord injury: counterpoint.
    Fehlings MG; Wilson JR; Cho N
    Neurosurgery; 2014 Aug; 61 Suppl 1():36-42. PubMed ID: 25032529
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylprednisolone for the treatment of acute spinal cord injury: point.
    Hurlbert RJ
    Neurosurgery; 2014 Aug; 61 Suppl 1():32-5. PubMed ID: 25032528
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury.
    N Engl J Med; 1990 Oct; 323(17):1207-9. PubMed ID: 2278580
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy.
    Fehlings MG
    Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S56-7. PubMed ID: 11805611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.